K34c is a potent and selective α5β1 integrin antagonist. By inhibiting α5β1 integrin , K34c reduces chemotherapy-induced premature senescence and promotes apoptosis . K34c can be used in glioblastoma research.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Integrin | Products > Signaling Pathways > Apoptosis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.